Project Grant 2127051
Award Date 8/1/21
Completion Date 7/31/22
Dollars Obligated $256K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Potomac, MD 20850, USA
Similar Awards
- Radiosight LLC was awarded a $256,000 Small Business Technology Transfer (STTR) Phase I Project Grant by the National Science Foundation on May 1, 2021 to develop a point-of-care skin cancer imaging device. The award is being carried out under the NSF's Technology, Innovation, and Partnerships program (CFDA 47.084) and will support Radiosight's efforts to advance science and engineering research leading to breakthrough technologies. Specifically, the funding will allow Radiosight to work towards...
- Bired Imaging Inc. received a $256,000 Small Business Innovation Research Phase I Project Grant from the National Science Foundation to develop an innovative breast cancer detection algorithm using infrared images. The 12-month project period runs from January 1, 2022 to December 31, 2022. The award is funded through the NSF's Directorate for Engineering, specifically its $47.041 million Engineering program. This program aims to improve quality of life and economic strength by fostering...
- This SBIR Phase I project, awarded by the National Science Foundation (NSF) through its Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop an innovative screening tool for early detection of breast cancer. The $305,000 award to Bired Imaging Inc. supports the efficient extraction of thermal-spatial point-cloud data from infrared images and the rapid assessment of physics-based AI algorithms to improve cancer detection, especially in women with dense breasts. The...
- Daignostx L.L.C. received a Phase I Small Business Technology Transfer (STTR) Project Grant of $306,798 from the National Cancer Institute under the Cancer Detection and Diagnosis Research program (CFDA 93.394) for the period of September 1, 2025, through August 31, 2026. The award supports the development of essential components for an artificial intelligence (AI)-based lymph node malignancy classification system designed to improve cancer diagnosis and treatment planning. The system aims to...
- The National Science Foundation Division of Industrial Innovation awarded Lumenastra $256,000 under the SBIR PHASE I Project Grant titled "A WEARABLE NON-INVASIVE DEEP TISSUE THERMOMETER." The award period runs from August 1, 2021 through July 31, 2022. The funding supports the development of a wearable, non-invasive deep tissue thermometer under the NSF's Engineering grant program (CFDA 47.041). This program seeks to foster innovation in engineering research and education to improve...
- Federal Grant Award Summary Illuminant Surgical Inc. received a $1,107,943 Project Grant award from the National Cancer Institute under the Cancer Detection and Diagnosis Research program (CFDA 93.394) on September 12, 2025, with a completion date of August 31, 2027. The company is developing and validating Skylight, a mixed-reality navigation platform designed to improve the accuracy and safety of computed tomography (CT)-guided biopsy procedures. The platform employs advanced computer vision...
- Cision Vision, Inc. received a $256,000 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041) to develop a novel, label-free imaging device for real-time detection of lymph nodes during laparoscopic cancer surgeries. The one-year project period runs from December 1, 2021 to November 30, 2022 and is focused on delivering a new imaging technology to improve cancer surgery outcomes. The NSF Engineering...
- This National Science Foundation Project Grant of $495,000 will support the development of biopsy-free, label-free three-dimensional virtual histology of intact skin through March 2025. Funded under the Engineering program (CFDA 47.041), the award to the University of California, Los Angeles aims to advance a machine learning-based technique to transform 3D skin images into virtually stained images that can facilitate accurate and rapid diagnosis of skin lesions without biopsy. Specifically, the...
- Visikol Inc. received a $4,103,265 Project Grant award from the National Cancer Institute, a division of the Department of Health and Human Services, under the Cancer Detection and Diagnosis Research program (CFDA 93.394). The award will support the development of a 3D imaging diagnostic tool to improve characterization of metastatic melanoma in sentinel lymph node biopsies. Visikol will conduct a retrospective clinical study using archived negative sentinel lymph node biopsy tissue blocks to...
- The National Science Foundation awarded Pensievision, Inc. $255,947 under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an endoscopic 3D imaging system for evaluating cancers and disorders of the esophagus and pharynx. The Small Business Innovation Research Phase I project will combine liquid lens technology, artificial intelligence software, and astronomical imaging techniques to generate three-dimensional images of early-stage esophageal and throat tumors....